These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15551729)

  • 1. Neuroendocrine cell markers for pancreatic islets and tumors.
    Portela-Gomes GM; Hacker GW; Weitgasser R
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):183-92. PubMed ID: 15551729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New markers for pancreatic islets and islet cell tumors.
    Tomita T
    Pathol Int; 2002 Jul; 52(7):425-32. PubMed ID: 12167099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
    Kasprzak A; Zabel M; Biczysko W
    Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic endocrine tumors.
    Asa SL
    Mod Pathol; 2011 Apr; 24 Suppl 2():S66-77. PubMed ID: 21455203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin A.
    Lai M; Lü B; Xing X; Xu E; Ren G; Huang Q
    Virchows Arch; 2006 Oct; 449(4):402-9. PubMed ID: 16955307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms.
    Lloyd RV; Mervak T; Schmidt K; Warner TF; Wilson BS
    Am J Surg Pathol; 1984 Aug; 8(8):607-14. PubMed ID: 6205601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry of pancreatic islet cell tumors in the ferret (Mustela putorius furo).
    Andrews GA; Myers NC; Chard-Bergstrom C
    Vet Pathol; 1997 Sep; 34(5):387-93. PubMed ID: 9381649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: their use as markers of neuroendocrine differentiation.
    Scopsi L; Gullo M; Rilke F; Martin S; Steiner DF
    J Clin Endocrinol Metab; 1995 Jan; 80(1):294-301. PubMed ID: 7829629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation.
    Mjønes P; Sagatun L; Nordrum IS; Waldum HL
    J Histochem Cytochem; 2017 Dec; 65(12):687-703. PubMed ID: 28972818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies.
    Lambertini C; Barzaghi-Rinaudo P; D'Amato L; Schulz S; Nuciforo P; Schmid HA
    Regul Pept; 2013 Nov; 187():35-41. PubMed ID: 24188818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin.
    Viale G; Doglioni C; Gambacorta M; Zamboni G; Coggi G; Bordi C
    Cancer; 1992 Nov; 70(9):2268-77. PubMed ID: 1356613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-Expression of Adaptor Protein FAM159B with Different Markers for Neuroendocrine Cells: An Immunocytochemical and Immunohistochemical Study.
    Beyer AL; Kaemmerer D; Sänger J; Lupp A
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical study of 17 cases of rectal neuroendocrine tumors].
    Chetritt J; Sagan C; Heymann MF; Le Bodic MF
    Ann Pathol; 1996; 16(2):98-103. PubMed ID: 8767675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine-like differentiation in patients with pancreatic carcinoma.
    Tezel E; Nagasaka T; Nomoto S; Sugimoto H; Nakao A
    Cancer; 2000 Dec; 89(11):2230-6. PubMed ID: 11147593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors.
    Said JW; Vimadalal S; Nash G; Shintaku IP; Heusser RC; Sassoon AF; Lloyd RV
    Hum Pathol; 1985 Mar; 16(3):236-40. PubMed ID: 3972403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats.
    Myers NC; Andrews GA; Chard-Bergstrom C
    Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors.
    Lorenzo PI; Jimenez Moreno CM; Delgado I; Cobo-Vuilleumier N; Meier R; Gomez-Izquierdo L; Berney T; Garcia-Carbonero R; Rojas A; Gauthier BR
    Histochem Cell Biol; 2011 Nov; 136(5):595-607. PubMed ID: 21932072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of somatostatin receptor 2A immunohistochemistry, RT-qPCR, and in vivo PET/CT data in patients with pancreatic neuroendocrine neoplasm.
    Kaemmerer D; Wirtz RM; Fischer EK; Hommann M; Sänger J; Prasad V; Specht E; Baum RP; Schulz S; Lupp A
    Pancreas; 2015 May; 44(4):648-54. PubMed ID: 25872131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases.
    Papotti M; Macrì L; Finzi G; Capella C; Eusebi V; Bussolati G
    Semin Diagn Pathol; 1989 May; 6(2):174-88. PubMed ID: 2503862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.